Streetbeat News

Equity Actions

RIVN

Rivian Automotive has priced its offering of $1.5 billion aggregate principal amount of 3.625% green convertible senior notes due 2030. The issuance and sale of the notes are scheduled to settle on October 10, 2023. Rivian also granted the initial purchasers an option to purchase up to an additional $225 million principal amount of notes.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 5:58 am

RIVN

TSLA

Jim Cramer expressed concerns about Rivian Automotive Inc (NASDAQ:RIVN) after the EV company announced a new $1.5 billion offering. Rivian intends to offer $1.5 billion of green convertible senior notes to institutional buyers. Cramer compared the company to Tesla Inc (NASDAQ:TSLA) but retracted his comments, stating that no one's the next Elon Musk. Rivian shares were down more than 22% at the last check and are now on the verge of turning negative for the year.

Portfolio Pulse from Adam Eckert

October 05, 2023 | 9:49 pm

HUGE

The Ontario Superior Court of Justice upheld a May arbitration decision in favor of FSD Pharma Inc. (NASDAQ:HUGE) against its former CEO Dr. Raza Bokhari over allegations of financial mismanagement. Following the ruling, FSD Pharma is set to recover the C$2.8 million awarded in May, with an additional 6% interest rate. In a separate development, FSD Pharma signed a strategic agreement with Celly Nutrition Corp., aiming to distribute a portion of its holdings in Celly Nu to shareholders.

Portfolio Pulse from Joana Scopel

October 05, 2023 | 9:23 pm

SLAM

Joseph Taeid has resigned as CFO of Slam Corp., effective September 30, 2023. Ryan Bright, with nearly 20 years of experience as a financial and investment executive, has been named as the new CFO, effective October 4, 2023.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 9:10 pm

SFE

Safeguard Scientifics' board has approved a plan to voluntarily terminate the registration of its common stock with the SEC and voluntarily delist from Nasdaq.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 9:01 pm

VTGN

Point72 Asset Management, L.P. has acquired a 5.6% passive stake in Vistagen Therapeutics, according to a 13G filing.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 8:52 pm

CLRB

Cellectar Biosciences Inc has filed for a shelf of up to 34.5 million shares of common stock by selling stockholders, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 8:50 pm

NIR

Near Intelligence has announced that it is withdrawing all previously issued revenue and adjusted EBITDA guidance, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 8:41 pm

NIR

Near Intelligence's board has placed CEO Anil Mathews, CFO Rahul Agarwal, and President Shobhit Shukla on administrative leave. The board has appointed COO and Secretary Gladys Kong as the interim CEO.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 8:40 pm

NIR

Near Intelligence has appointed John Faieta, the company's controller, as the interim CFO. The board has also formed a committee to oversee an internal investigation conducted by outside counsel.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 8:38 pm